United States · 
Who invested in Rgenta Therapeutics?
Rgenta Therapeutics's investors include Matrix Partners China, Vivo Capital, Lilly Asia Ventures and Highlight Capital.
United States · Series A startup
Who invested in Rgenta Therapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$8.0Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $8.0MMay 2023
- Investors
- 4
The rounds
- May 2023
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Rgenta Therapeutics
How much has Rgenta Therapeutics raised?
Rgenta Therapeutics has raised $8.0M across 1 round since 2023.
When did Rgenta Therapeutics last raise?
Rgenta Therapeutics's most recent round was a Series A of $8.0M in May 2023.
What was Rgenta Therapeutics's biggest round?
Its most recent round, $8.0M in May 2023, is also its largest on record.
Who backed Rgenta Therapeutics first?
Rgenta Therapeutics's first round on record, in May 2023, was backed by Matrix Partners China, Vivo Capital and Lilly Asia Ventures and 1 others.
What stage is Rgenta Therapeutics at?
Rgenta Therapeutics's latest named round is a Series A, in May 2023.
Where is Rgenta Therapeutics based?
Rgenta Therapeutics is based in the United States.
Companies like Rgenta Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.